

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of gene silencing by RNA (GO:0060966) | 5.41669340 |
| 2 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.41669340 |
| 3 | regulation of gene silencing by miRNA (GO:0060964) | 5.41669340 |
| 4 | regulation of helicase activity (GO:0051095) | 4.86785402 |
| 5 | response to peptidoglycan (GO:0032494) | 4.76815053 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 4.61849351 |
| 7 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.61594101 |
| 8 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.55747219 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.55556206 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 4.48974644 |
| 11 | nucleobase biosynthetic process (GO:0046112) | 4.46563458 |
| 12 | purine nucleobase biosynthetic process (GO:0009113) | 4.27346067 |
| 13 | nuclear pore organization (GO:0006999) | 4.23778696 |
| 14 | ribosome assembly (GO:0042255) | 4.19910656 |
| 15 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.18682475 |
| 16 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.18682475 |
| 17 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.18148958 |
| 18 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.18148958 |
| 19 | DNA replication initiation (GO:0006270) | 4.12123789 |
| 20 | hemidesmosome assembly (GO:0031581) | 4.07516506 |
| 21 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.06756487 |
| 22 | mitotic metaphase plate congression (GO:0007080) | 4.01082991 |
| 23 | maturation of SSU-rRNA (GO:0030490) | 4.00419382 |
| 24 | IMP biosynthetic process (GO:0006188) | 4.00099660 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.91905707 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.89265087 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.89265087 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.89265087 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.89265087 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.89265087 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 3.89265087 |
| 32 | mitotic nuclear envelope disassembly (GO:0007077) | 3.88345800 |
| 33 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.88053339 |
| 34 | determination of adult lifespan (GO:0008340) | 3.84932185 |
| 35 | nuclear pore complex assembly (GO:0051292) | 3.81280853 |
| 36 | protein localization to kinetochore (GO:0034501) | 3.74702256 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.72466249 |
| 38 | leukocyte aggregation (GO:0070486) | 3.69506126 |
| 39 | DNA strand elongation (GO:0022616) | 3.68766567 |
| 40 | granulocyte activation (GO:0036230) | 3.62648394 |
| 41 | nuclear envelope disassembly (GO:0051081) | 3.61712377 |
| 42 | membrane disassembly (GO:0030397) | 3.61712377 |
| 43 | ribosome biogenesis (GO:0042254) | 3.60846263 |
| 44 | anterior/posterior axis specification, embryo (GO:0008595) | 3.59145324 |
| 45 | DNA replication checkpoint (GO:0000076) | 3.57530063 |
| 46 | regulation of podosome assembly (GO:0071801) | 3.57358419 |
| 47 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.55744046 |
| 48 | DNA unwinding involved in DNA replication (GO:0006268) | 3.51346752 |
| 49 | ribosomal large subunit biogenesis (GO:0042273) | 3.48078914 |
| 50 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.42543606 |
| 51 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.41562342 |
| 52 | ribosomal small subunit assembly (GO:0000028) | 3.40779854 |
| 53 | IMP metabolic process (GO:0046040) | 3.39305568 |
| 54 | metaphase plate congression (GO:0051310) | 3.39287741 |
| 55 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.39068370 |
| 56 | regulation of vitamin metabolic process (GO:0030656) | 3.37409143 |
| 57 | heterochromatin organization (GO:0070828) | 3.37229184 |
| 58 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.34114279 |
| 59 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.33102623 |
| 60 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.32516341 |
| 61 | protein K6-linked ubiquitination (GO:0085020) | 3.32285594 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 3.29502477 |
| 63 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.29370114 |
| 64 | regulation of chemokine biosynthetic process (GO:0045073) | 3.27242825 |
| 65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.27115584 |
| 66 | negative regulation of cell killing (GO:0031342) | 3.27115584 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.25357097 |
| 68 | regulation of histone H3-K9 methylation (GO:0051570) | 3.23242958 |
| 69 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.22670036 |
| 70 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.21874094 |
| 71 | regulation of chronic inflammatory response (GO:0002676) | 3.19557892 |
| 72 | detection of other organism (GO:0098543) | 3.17456043 |
| 73 | nodal signaling pathway (GO:0038092) | 3.16890739 |
| 74 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16599301 |
| 75 | translational termination (GO:0006415) | 3.16317515 |
| 76 | negative regulation of histone methylation (GO:0031061) | 3.15757252 |
| 77 | viral transcription (GO:0019083) | 3.15452259 |
| 78 | regulation of gene silencing (GO:0060968) | 3.14607882 |
| 79 | ribosomal small subunit biogenesis (GO:0042274) | 3.14265455 |
| 80 | immunoglobulin mediated immune response (GO:0016064) | 3.12414324 |
| 81 | histone H4-K12 acetylation (GO:0043983) | 3.12001149 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.11143492 |
| 83 | telomere maintenance via recombination (GO:0000722) | 3.11043626 |
| 84 | DNA geometric change (GO:0032392) | 3.10989284 |
| 85 | neutrophil activation (GO:0042119) | 3.09988866 |
| 86 | protein localization to endosome (GO:0036010) | 3.09810888 |
| 87 | DNA duplex unwinding (GO:0032508) | 3.09665698 |
| 88 | translational initiation (GO:0006413) | 3.09643608 |
| 89 | cellular response to type I interferon (GO:0071357) | 3.07737364 |
| 90 | type I interferon signaling pathway (GO:0060337) | 3.07737364 |
| 91 | myeloid cell activation involved in immune response (GO:0002275) | 3.07466556 |
| 92 | intestinal epithelial cell development (GO:0060576) | 3.05587525 |
| 93 | negative regulation of gene silencing (GO:0060969) | 3.03663055 |
| 94 | response to type I interferon (GO:0034340) | 3.03553769 |
| 95 | establishment of chromosome localization (GO:0051303) | 3.03193524 |
| 96 | establishment of integrated proviral latency (GO:0075713) | 3.02600227 |
| 97 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.02263002 |
| 98 | detection of bacterium (GO:0016045) | 3.01350257 |
| 99 | telomere maintenance via telomere lengthening (GO:0010833) | 3.01084931 |
| 100 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.99895448 |
| 101 | paraxial mesoderm development (GO:0048339) | 2.99756009 |
| 102 | chromatin remodeling at centromere (GO:0031055) | 2.99570910 |
| 103 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.98416225 |
| 104 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.98398199 |
| 105 | response to protozoan (GO:0001562) | 2.97912426 |
| 106 | T-helper 1 type immune response (GO:0042088) | 2.97438343 |
| 107 | pore complex assembly (GO:0046931) | 2.96457286 |
| 108 | rRNA processing (GO:0006364) | 2.96089148 |
| 109 | mitotic recombination (GO:0006312) | 2.95948957 |
| 110 | regulation of spindle organization (GO:0090224) | 2.95774163 |
| 111 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.95708982 |
| 112 | protein localization to chromosome, centromeric region (GO:0071459) | 2.95045628 |
| 113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.93703513 |
| 114 | defense response to protozoan (GO:0042832) | 2.93667319 |
| 115 | translational elongation (GO:0006414) | 2.92328181 |
| 116 | regulation of mitotic spindle organization (GO:0060236) | 2.91452869 |
| 117 | establishment of apical/basal cell polarity (GO:0035089) | 2.90918479 |
| 118 | cellular extravasation (GO:0045123) | 2.90632064 |
| 119 | monocyte chemotaxis (GO:0002548) | 2.90245969 |
| 120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90151896 |
| 121 | cellular response to zinc ion (GO:0071294) | 2.90125433 |
| 122 | histone arginine methylation (GO:0034969) | 2.89974196 |
| 123 | glycosphingolipid catabolic process (GO:0046479) | 2.88729665 |
| 124 | regulation of translational fidelity (GO:0006450) | 2.88163466 |
| 125 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.87820942 |
| 126 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.87662283 |
| 127 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.86301817 |
| 128 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.85985523 |
| 129 | rRNA metabolic process (GO:0016072) | 2.85865300 |
| 130 | mismatch repair (GO:0006298) | 2.85394337 |
| 131 | pre-miRNA processing (GO:0031054) | 2.84686757 |
| 132 | regulation of translation in response to stress (GO:0043555) | 2.83669451 |
| 133 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83405670 |
| 134 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83392258 |
| 135 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.82785196 |
| 136 | germinal center formation (GO:0002467) | 2.82264903 |
| 137 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.81117766 |
| 138 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.80487810 |
| 139 | positive regulation of interleukin-6 production (GO:0032755) | 2.80439738 |
| 140 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.79686952 |
| 141 | rRNA modification (GO:0000154) | 2.79667231 |
| 142 | regulation of mast cell degranulation (GO:0043304) | 2.79601587 |
| 143 | myeloid dendritic cell activation (GO:0001773) | 2.78912941 |
| 144 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.78652662 |
| 145 | regulation of T cell tolerance induction (GO:0002664) | 2.78616817 |
| 146 | folic acid metabolic process (GO:0046655) | 2.77794139 |
| 147 | mitotic sister chromatid segregation (GO:0000070) | 2.77417277 |
| 148 | CENP-A containing nucleosome assembly (GO:0034080) | 2.76992371 |
| 149 | macrophage activation (GO:0042116) | 2.76730324 |
| 150 | activation of MAPKKK activity (GO:0000185) | 2.76381423 |
| 151 | amino sugar catabolic process (GO:0046348) | 2.75136128 |
| 152 | spliceosomal snRNP assembly (GO:0000387) | 2.74737504 |
| 153 | positive regulation of chromosome segregation (GO:0051984) | 2.74436945 |
| 154 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.74150511 |
| 155 | negative regulation of T cell mediated immunity (GO:0002710) | 2.73041561 |
| 156 | positive regulation of hair follicle development (GO:0051798) | 2.72673337 |
| 157 | positive regulation of hair cycle (GO:0042635) | 2.72673337 |
| 158 | detection of molecule of bacterial origin (GO:0032490) | 2.72193663 |
| 159 | cellular response to arsenic-containing substance (GO:0071243) | 2.71914101 |
| 160 | regulation of interleukin-6 production (GO:0032675) | 2.71631204 |
| 161 | tetrahydrofolate metabolic process (GO:0046653) | 2.71226273 |
| 162 | respiratory burst (GO:0045730) | 2.70473733 |
| 163 | regulation of interferon-alpha production (GO:0032647) | 2.70330980 |
| 164 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.70330629 |
| 165 | negative regulation of interleukin-17 production (GO:0032700) | 2.70028654 |
| 166 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.68875256 |
| 167 | detection of external biotic stimulus (GO:0098581) | 2.68838508 |
| 168 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67830253 |
| 169 | cellular response to lipopolysaccharide (GO:0071222) | 2.67056968 |
| 170 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66900006 |
| 171 | chaperone-mediated protein complex assembly (GO:0051131) | 2.66718210 |
| 172 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.66615017 |
| 173 | DNA replication-independent nucleosome organization (GO:0034724) | 2.66615017 |
| 174 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.66305100 |
| 175 | proteasome assembly (GO:0043248) | 2.66083093 |
| 176 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.66027330 |
| 177 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.65223625 |
| 178 | nuclear envelope organization (GO:0006998) | 2.64782933 |
| 179 | transcription from RNA polymerase I promoter (GO:0006360) | 2.64440548 |
| 180 | negative regulation by host of viral transcription (GO:0043922) | 2.63747481 |
| 181 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.63581948 |
| 182 | cell cycle G1/S phase transition (GO:0044843) | 2.63581948 |
| 183 | regulation of centrosome cycle (GO:0046605) | 2.63478783 |
| 184 | cellular response to molecule of bacterial origin (GO:0071219) | 2.61918553 |
| 185 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.61403877 |
| 186 | myeloid leukocyte activation (GO:0002274) | 2.60281873 |
| 187 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.60034353 |
| 188 | regulation of mononuclear cell migration (GO:0071675) | 2.58936461 |
| 189 | regulation of leukocyte degranulation (GO:0043300) | 2.58700185 |
| 190 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.58522145 |
| 191 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.57369371 |
| 192 | decidualization (GO:0046697) | 2.57314776 |
| 193 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.55401383 |
| 194 | regulation of monocyte chemotaxis (GO:0090025) | 2.54671677 |
| 195 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.54257571 |
| 196 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.53514773 |
| 197 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.53499036 |
| 198 | glycolipid catabolic process (GO:0019377) | 2.53388985 |
| 199 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.51824767 |
| 200 | regulation of interleukin-17 production (GO:0032660) | 2.51444282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.35377449 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.11452419 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.93138693 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.40376025 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.36328181 |
| 6 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.16509174 |
| 7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.16418222 |
| 8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.16418222 |
| 9 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.16418222 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.09256827 |
| 11 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.96472857 |
| 12 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.95265405 |
| 13 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.91720473 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.87799094 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.85558490 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.72175007 |
| 17 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.69744199 |
| 18 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.65205032 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64052050 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52407558 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.49187368 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46040545 |
| 23 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.43891085 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.43826532 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.41282368 |
| 26 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.40781589 |
| 27 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38030617 |
| 28 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.36202655 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32541721 |
| 30 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.32500062 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29072451 |
| 32 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.26598490 |
| 33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.25024602 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23432197 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22049572 |
| 36 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.13822998 |
| 37 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.12087784 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.09377394 |
| 39 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 2.08783431 |
| 40 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.07197791 |
| 41 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.04874382 |
| 42 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.04663177 |
| 43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.03753014 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.01239915 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00601810 |
| 46 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98997611 |
| 47 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98816538 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97964240 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.97392361 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.94164793 |
| 51 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.92528249 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90893436 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90343118 |
| 54 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.89291002 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88339990 |
| 56 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.87687579 |
| 57 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86496098 |
| 58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.85294919 |
| 59 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84639572 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81080136 |
| 61 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80015380 |
| 62 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.77748306 |
| 63 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.77724563 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77227469 |
| 65 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.76925864 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75706279 |
| 67 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.75072503 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74736420 |
| 69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.73866698 |
| 70 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.69860573 |
| 71 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.68491354 |
| 72 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.65668872 |
| 73 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64969830 |
| 74 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.64143425 |
| 75 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61464872 |
| 76 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.60765919 |
| 77 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.59946997 |
| 78 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.59512138 |
| 79 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.59512138 |
| 80 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.57839674 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56406231 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54779049 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 1.53329736 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52201905 |
| 85 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.51598405 |
| 86 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.49541566 |
| 87 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.49480587 |
| 88 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.48560092 |
| 89 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.48099986 |
| 90 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.47692623 |
| 91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47513426 |
| 92 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.47266629 |
| 93 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.47057155 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46791579 |
| 95 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.46273445 |
| 96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.45019777 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44222064 |
| 98 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43383779 |
| 99 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.41160357 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40275001 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40188351 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.40031920 |
| 103 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.37456549 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37268626 |
| 105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37055959 |
| 106 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.37052941 |
| 107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35064100 |
| 108 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.34104614 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33855046 |
| 110 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.33025727 |
| 111 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32716571 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.32279879 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31309557 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29501394 |
| 115 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.29433697 |
| 116 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.29171096 |
| 117 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.28261502 |
| 118 | * MAF_26560356_Chip-Seq_TH2_Human | 1.27679923 |
| 119 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.26588737 |
| 120 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25975033 |
| 121 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25551088 |
| 122 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.24055554 |
| 123 | MYB_26560356_Chip-Seq_TH2_Human | 1.23811331 |
| 124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22169020 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22135740 |
| 126 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20608903 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19823094 |
| 128 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19483400 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18613925 |
| 130 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.18475116 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18186772 |
| 132 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17203066 |
| 133 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.16901900 |
| 134 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16883104 |
| 135 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16577151 |
| 136 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.16364394 |
| 137 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16335914 |
| 138 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15467948 |
| 139 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14734116 |
| 140 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14027343 |
| 141 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13380174 |
| 142 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13255639 |
| 143 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13216734 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12503249 |
| 145 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12068682 |
| 146 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11297931 |
| 147 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10866167 |
| 148 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10539382 |
| 149 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.08596350 |
| 150 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07787824 |
| 151 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07681073 |
| 152 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07543417 |
| 153 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07525507 |
| 154 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05727227 |
| 155 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04905588 |
| 156 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04121837 |
| 157 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03459744 |
| 158 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03377172 |
| 159 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03058559 |
| 160 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02687216 |
| 161 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02650704 |
| 162 | MYB_26560356_Chip-Seq_TH1_Human | 1.01106934 |
| 163 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00991831 |
| 164 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00927186 |
| 165 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00313830 |
| 166 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00208019 |
| 167 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98612655 |
| 168 | MYC_22102868_ChIP-Seq_BL_Human | 0.97925856 |
| 169 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97671288 |
| 170 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97398812 |
| 171 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97218848 |
| 172 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96248951 |
| 173 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95949225 |
| 174 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95901844 |
| 175 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95697809 |
| 176 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95580222 |
| 177 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.95407255 |
| 178 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93814675 |
| 179 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.91846754 |
| 180 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91301484 |
| 181 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90260858 |
| 182 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.89027438 |
| 183 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88416665 |
| 184 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87029524 |
| 185 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.87001124 |
| 186 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84309540 |
| 187 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.83778636 |
| 188 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.81971140 |
| 189 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81532460 |
| 190 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.81147166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.67390365 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.45459548 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.86950555 |
| 4 | MP0008057_abnormal_DNA_replication | 3.78482428 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.72501876 |
| 6 | MP0003436_decreased_susceptibility_to | 3.70147187 |
| 7 | MP0003303_peritoneal_inflammation | 3.60983526 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 3.49692290 |
| 9 | MP0003077_abnormal_cell_cycle | 3.46473475 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.33510072 |
| 11 | MP0006082_CNS_inflammation | 3.03890587 |
| 12 | MP0009840_abnormal_foam_cell | 2.92292924 |
| 13 | MP0008058_abnormal_DNA_repair | 2.91617014 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.82224463 |
| 15 | MP0004133_heterotaxia | 2.80945592 |
| 16 | MP0002419_abnormal_innate_immunity | 2.65939601 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.58110120 |
| 18 | MP0005671_abnormal_response_to | 2.54589106 |
| 19 | MP0004510_myositis | 2.53076932 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.52302773 |
| 21 | MP0004947_skin_inflammation | 2.50216728 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.43546987 |
| 23 | MP0002653_abnormal_ependyma_morphology | 2.43220832 |
| 24 | MP0005451_abnormal_body_composition | 2.39819347 |
| 25 | MP0005025_abnormal_response_to | 2.36693248 |
| 26 | MP0001730_embryonic_growth_arrest | 2.35201593 |
| 27 | MP0008932_abnormal_embryonic_tissue | 2.23972292 |
| 28 | MP0003941_abnormal_skin_development | 2.22642375 |
| 29 | MP0000350_abnormal_cell_proliferation | 2.20535890 |
| 30 | MP0001790_abnormal_immune_system | 2.17528819 |
| 31 | MP0005387_immune_system_phenotype | 2.17528819 |
| 32 | MP0002452_abnormal_antigen_presenting | 2.14768361 |
| 33 | MP0001853_heart_inflammation | 2.09974459 |
| 34 | MP0002723_abnormal_immune_serum | 2.08161315 |
| 35 | MP0009764_decreased_sensitivity_to | 2.05156332 |
| 36 | MP0008007_abnormal_cellular_replicative | 2.03828297 |
| 37 | MP0003123_paternal_imprinting | 2.02970763 |
| 38 | MP0010307_abnormal_tumor_latency | 2.02705634 |
| 39 | MP0000343_altered_response_to | 2.02402454 |
| 40 | MP0003075_altered_response_to | 2.01549258 |
| 41 | MP0003718_maternal_effect | 1.99991461 |
| 42 | MP0003283_abnormal_digestive_organ | 1.99093846 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.95016326 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.92232055 |
| 45 | MP0001800_abnormal_humoral_immune | 1.92113396 |
| 46 | * MP0003806_abnormal_nucleotide_metabolis | 1.90496544 |
| 47 | MP0005380_embryogenesis_phenotype | 1.87646101 |
| 48 | MP0001672_abnormal_embryogenesis/_devel | 1.87646101 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.86057515 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.85440409 |
| 51 | MP0001819_abnormal_immune_cell | 1.85219007 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.82621339 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.81183435 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.79235155 |
| 55 | MP0002086_abnormal_extraembryonic_tissu | 1.78669258 |
| 56 | MP0002084_abnormal_developmental_patter | 1.76239895 |
| 57 | MP0000490_abnormal_crypts_of | 1.74015220 |
| 58 | MP0003119_abnormal_digestive_system | 1.72766146 |
| 59 | MP0000685_abnormal_immune_system | 1.72218072 |
| 60 | MP0002085_abnormal_embryonic_tissue | 1.68530628 |
| 61 | MP0003566_abnormal_cell_adhesion | 1.65581258 |
| 62 | MP0001697_abnormal_embryo_size | 1.64822588 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.64188869 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.63774338 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.62088063 |
| 66 | MP0003786_premature_aging | 1.61436531 |
| 67 | MP0003984_embryonic_growth_retardation | 1.61217616 |
| 68 | MP0004197_abnormal_fetal_growth/weight/ | 1.59040204 |
| 69 | MP0002405_respiratory_system_inflammati | 1.58925984 |
| 70 | MP0003186_abnormal_redox_activity | 1.58675293 |
| 71 | MP0002088_abnormal_embryonic_growth/wei | 1.58245385 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.58131707 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.56571179 |
| 74 | MP0002080_prenatal_lethality | 1.53638424 |
| 75 | MP0003136_yellow_coat_color | 1.50940896 |
| 76 | MP0000604_amyloidosis | 1.50247703 |
| 77 | MP0006292_abnormal_olfactory_placode | 1.42547270 |
| 78 | MP0008469_abnormal_protein_level | 1.42335728 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.41827346 |
| 80 | MP0001293_anophthalmia | 1.38499312 |
| 81 | MP0008004_abnormal_stomach_pH | 1.36894642 |
| 82 | MP0005166_decreased_susceptibility_to | 1.35750958 |
| 83 | MP0001216_abnormal_epidermal_layer | 1.35523870 |
| 84 | MP0005023_abnormal_wound_healing | 1.33609494 |
| 85 | MP0008877_abnormal_DNA_methylation | 1.32561472 |
| 86 | MP0005310_abnormal_salivary_gland | 1.30410723 |
| 87 | MP0003828_pulmonary_edema | 1.28934194 |
| 88 | MP0001849_ear_inflammation | 1.28861457 |
| 89 | MP0000716_abnormal_immune_system | 1.28462965 |
| 90 | MP0000313_abnormal_cell_death | 1.27404962 |
| 91 | MP0003567_abnormal_fetal_cardiomyocyte | 1.26905380 |
| 92 | MP0005164_abnormal_response_to | 1.23158931 |
| 93 | MP0000516_abnormal_urinary_system | 1.22641785 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 1.22641785 |
| 95 | MP0003950_abnormal_plasma_membrane | 1.19890096 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 1.19831303 |
| 97 | MP0002254_reproductive_system_inflammat | 1.19672285 |
| 98 | MP0003763_abnormal_thymus_physiology | 1.18480798 |
| 99 | MP0002019_abnormal_tumor_incidence | 1.12428016 |
| 100 | MP0001851_eye_inflammation | 1.12341863 |
| 101 | MP0000858_altered_metastatic_potential | 1.11581570 |
| 102 | MP0006054_spinal_hemorrhage | 1.10508373 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 1.08819983 |
| 104 | MP0009278_abnormal_bone_marrow | 1.08529958 |
| 105 | MP0002398_abnormal_bone_marrow | 1.04276691 |
| 106 | MP0003315_abnormal_perineum_morphology | 1.03998022 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 1.03714054 |
| 108 | * MP0005266_abnormal_metabolism | 1.03595419 |
| 109 | MP0002210_abnormal_sex_determination | 1.01958550 |
| 110 | MP0002429_abnormal_blood_cell | 1.01016599 |
| 111 | MP0004381_abnormal_hair_follicle | 1.00946059 |
| 112 | MP0005165_increased_susceptibility_to | 1.00040127 |
| 113 | MP0003448_altered_tumor_morphology | 0.99579418 |
| 114 | MP0003329_amyloid_beta_deposits | 0.98156898 |
| 115 | MP0000579_abnormal_nail_morphology | 0.97705863 |
| 116 | MP0003091_abnormal_cell_migration | 0.97261565 |
| 117 | MP0001145_abnormal_male_reproductive | 0.96079492 |
| 118 | MP0010030_abnormal_orbit_morphology | 0.92117884 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.90099431 |
| 120 | MP0009763_increased_sensitivity_to | 0.88670763 |
| 121 | MP0000358_abnormal_cell_content/ | 0.88289524 |
| 122 | MP0005621_abnormal_cell_physiology | 0.86954702 |
| 123 | MP0001873_stomach_inflammation | 0.85609125 |
| 124 | MP0005384_cellular_phenotype | 0.85122712 |
| 125 | MP0000689_abnormal_spleen_morphology | 0.84981921 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.84737388 |
| 127 | MP0002060_abnormal_skin_morphology | 0.84701416 |
| 128 | MP0002796_impaired_skin_barrier | 0.83990071 |
| 129 | MP0003121_genomic_imprinting | 0.83411906 |
| 130 | MP0005501_abnormal_skin_physiology | 0.82588224 |
| 131 | MP0002111_abnormal_tail_morphology | 0.81840090 |
| 132 | MP0000371_diluted_coat_color | 0.81113525 |
| 133 | MP0000537_abnormal_urethra_morphology | 0.81017879 |
| 134 | MP0003656_abnormal_erythrocyte_physiolo | 0.80734223 |
| 135 | MP0005395_other_phenotype | 0.78983150 |
| 136 | MP0005390_skeleton_phenotype | 0.77406800 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.73989042 |
| 138 | MP0001915_intracranial_hemorrhage | 0.73918737 |
| 139 | MP0000653_abnormal_sex_gland | 0.71187191 |
| 140 | MP0009053_abnormal_anal_canal | 0.71021994 |
| 141 | MP0000750_abnormal_muscle_regeneration | 0.70599688 |
| 142 | MP0003690_abnormal_glial_cell | 0.69416433 |
| 143 | MP0000920_abnormal_myelination | 0.68753361 |
| 144 | MP0001191_abnormal_skin_condition | 0.68445114 |
| 145 | MP0001663_abnormal_digestive_system | 0.68004267 |
| 146 | MP0010678_abnormal_skin_adnexa | 0.66963990 |
| 147 | MP0000015_abnormal_ear_pigmentation | 0.66169726 |
| 148 | MP0001929_abnormal_gametogenesis | 0.66094473 |
| 149 | MP0003936_abnormal_reproductive_system | 0.65769437 |
| 150 | MP0002075_abnormal_coat/hair_pigmentati | 0.65286046 |
| 151 | MP0001119_abnormal_female_reproductive | 0.64404949 |
| 152 | MP0000678_abnormal_parathyroid_gland | 0.64127950 |
| 153 | MP0010771_integument_phenotype | 0.63501911 |
| 154 | MP0003795_abnormal_bone_structure | 0.63427996 |
| 155 | MP0001286_abnormal_eye_development | 0.63405863 |
| 156 | MP0001542_abnormal_bone_strength | 0.63194343 |
| 157 | MP0005397_hematopoietic_system_phenotyp | 0.63042903 |
| 158 | MP0001545_abnormal_hematopoietic_system | 0.63042903 |
| 159 | MP0008260_abnormal_autophagy | 0.61472641 |
| 160 | MP0009333_abnormal_splenocyte_physiolog | 0.61123749 |
| 161 | MP0000470_abnormal_stomach_morphology | 0.58882779 |
| 162 | MP0001186_pigmentation_phenotype | 0.57683623 |
| 163 | MP0002127_abnormal_cardiovascular_syste | 0.57282827 |
| 164 | MP0002925_abnormal_cardiovascular_devel | 0.56881096 |
| 165 | MP0005389_reproductive_system_phenotype | 0.56501309 |
| 166 | MP0002697_abnormal_eye_size | 0.55852895 |
| 167 | MP0003724_increased_susceptibility_to | 0.55003613 |
| 168 | MP0009785_altered_susceptibility_to | 0.54779526 |
| 169 | MP0000432_abnormal_head_morphology | 0.52769846 |
| 170 | MP0010155_abnormal_intestine_physiology | 0.51243241 |
| 171 | MP0002722_abnormal_immune_system | 0.50544850 |
| 172 | MP0002160_abnormal_reproductive_system | 0.49398702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.39952843 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.39952843 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.39952843 |
| 4 | Ependymoma (HP:0002888) | 5.12301340 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.91620629 |
| 6 | Breast hypoplasia (HP:0003187) | 4.54095726 |
| 7 | Birth length less than 3rd percentile (HP:0003561) | 4.53284071 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.37078551 |
| 9 | Thick nail (HP:0001805) | 4.32154547 |
| 10 | Agnosia (HP:0010524) | 4.29766338 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 4.25752046 |
| 12 | Stomatitis (HP:0010280) | 4.00091769 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.92971735 |
| 14 | Milia (HP:0001056) | 3.84529757 |
| 15 | Loss of speech (HP:0002371) | 3.82456911 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.82406430 |
| 17 | Medulloblastoma (HP:0002885) | 3.62817013 |
| 18 | Absent radius (HP:0003974) | 3.62412978 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.59089158 |
| 20 | Reticulocytopenia (HP:0001896) | 3.58218986 |
| 21 | Abnormality of the labia minora (HP:0012880) | 3.56793657 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.56593304 |
| 23 | Orchitis (HP:0100796) | 3.51839261 |
| 24 | Colon cancer (HP:0003003) | 3.50705582 |
| 25 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.45482380 |
| 26 | Myositis (HP:0100614) | 3.43604072 |
| 27 | Neurofibrillary tangles (HP:0002185) | 3.42927009 |
| 28 | Aplasia involving forearm bones (HP:0009822) | 3.38039748 |
| 29 | Absent forearm bone (HP:0003953) | 3.38039748 |
| 30 | Astrocytoma (HP:0009592) | 3.33388845 |
| 31 | Abnormality of the astrocytes (HP:0100707) | 3.33388845 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.33152726 |
| 33 | Optic neuritis (HP:0100653) | 3.33152726 |
| 34 | Onycholysis (HP:0001806) | 3.32079600 |
| 35 | Neoplasm of the oral cavity (HP:0100649) | 3.27719557 |
| 36 | Carpal bone hypoplasia (HP:0001498) | 3.27384544 |
| 37 | Oral leukoplakia (HP:0002745) | 3.22084104 |
| 38 | Rough bone trabeculation (HP:0100670) | 3.21263407 |
| 39 | Axonal loss (HP:0003447) | 3.19954579 |
| 40 | Supernumerary spleens (HP:0009799) | 3.18682254 |
| 41 | Rhabdomyosarcoma (HP:0002859) | 3.18305785 |
| 42 | Selective tooth agenesis (HP:0001592) | 3.17511698 |
| 43 | Short humerus (HP:0005792) | 3.14066015 |
| 44 | Nail dystrophy (HP:0008404) | 3.13547975 |
| 45 | Plantar hyperkeratosis (HP:0007556) | 3.13350959 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11917216 |
| 47 | Pustule (HP:0200039) | 3.09571331 |
| 48 | Degeneration of anterior horn cells (HP:0002398) | 3.08677025 |
| 49 | Abnormality of the anterior horn cell (HP:0006802) | 3.08677025 |
| 50 | Fragile nails (HP:0001808) | 3.08258174 |
| 51 | Chromsome breakage (HP:0040012) | 3.05917328 |
| 52 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.04042616 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 3.02771801 |
| 54 | Glioma (HP:0009733) | 2.97536972 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.97022666 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.92871540 |
| 57 | Abnormality of the salivary glands (HP:0010286) | 2.91848901 |
| 58 | Alopecia of scalp (HP:0002293) | 2.90169522 |
| 59 | Stenosis of the external auditory canal (HP:0000402) | 2.88987465 |
| 60 | Rib fusion (HP:0000902) | 2.87125988 |
| 61 | Abnormality of nail color (HP:0100643) | 2.83861886 |
| 62 | Absent thumb (HP:0009777) | 2.77979457 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.76106398 |
| 64 | Patellar aplasia (HP:0006443) | 2.76056652 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.75045394 |
| 66 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.72970151 |
| 67 | Biliary tract neoplasm (HP:0100574) | 2.71998128 |
| 68 | Missing ribs (HP:0000921) | 2.71540604 |
| 69 | Fused cervical vertebrae (HP:0002949) | 2.71241016 |
| 70 | Parakeratosis (HP:0001036) | 2.70637123 |
| 71 | Abdominal situs inversus (HP:0003363) | 2.69481151 |
| 72 | Abnormality of abdominal situs (HP:0011620) | 2.69481151 |
| 73 | Disinhibition (HP:0000734) | 2.68915321 |
| 74 | Rectovaginal fistula (HP:0000143) | 2.68716266 |
| 75 | Rectal fistula (HP:0100590) | 2.68716266 |
| 76 | Supranuclear gaze palsy (HP:0000605) | 2.66978820 |
| 77 | Esophageal atresia (HP:0002032) | 2.61978893 |
| 78 | Abnormal blistering of the skin (HP:0008066) | 2.61076892 |
| 79 | Spinal muscular atrophy (HP:0007269) | 2.59727207 |
| 80 | Mutism (HP:0002300) | 2.59650200 |
| 81 | Neoplasm of the pancreas (HP:0002894) | 2.56349125 |
| 82 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.55302296 |
| 83 | Premature graying of hair (HP:0002216) | 2.54922794 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 2.53893774 |
| 85 | Amaurosis fugax (HP:0100576) | 2.52527188 |
| 86 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.52325376 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51670673 |
| 88 | Meckel diverticulum (HP:0002245) | 2.50041786 |
| 89 | Increased serum ferritin (HP:0003281) | 2.49857065 |
| 90 | Impulsivity (HP:0100710) | 2.49613496 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.48839595 |
| 92 | Obstructive lung disease (HP:0006536) | 2.48120600 |
| 93 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48120600 |
| 94 | Abnormality of chromosome stability (HP:0003220) | 2.47203430 |
| 95 | Premature ovarian failure (HP:0008209) | 2.46684725 |
| 96 | Trismus (HP:0000211) | 2.46211090 |
| 97 | Urticaria (HP:0001025) | 2.45482688 |
| 98 | Shawl scrotum (HP:0000049) | 2.44005772 |
| 99 | Petechiae (HP:0000967) | 2.43286713 |
| 100 | Abnormality of the ileum (HP:0001549) | 2.43053319 |
| 101 | Tracheoesophageal fistula (HP:0002575) | 2.42555948 |
| 102 | Amyloidosis (HP:0011034) | 2.42442422 |
| 103 | Palmoplantar hyperkeratosis (HP:0000972) | 2.40626857 |
| 104 | Multiple enchondromatosis (HP:0005701) | 2.40135611 |
| 105 | Recurrent skin infections (HP:0001581) | 2.39555750 |
| 106 | Abnormal trabecular bone morphology (HP:0100671) | 2.39545026 |
| 107 | Neoplasm of striated muscle (HP:0009728) | 2.37509709 |
| 108 | Metaphyseal cupping (HP:0003021) | 2.37319487 |
| 109 | Atrophic scars (HP:0001075) | 2.36021045 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 2.35833619 |
| 111 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.35632771 |
| 112 | Abnormality of the preputium (HP:0100587) | 2.33957932 |
| 113 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.33409960 |
| 114 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.33145812 |
| 115 | Apathy (HP:0000741) | 2.31592114 |
| 116 | Systemic lupus erythematosus (HP:0002725) | 2.31567914 |
| 117 | Gangrene (HP:0100758) | 2.30208307 |
| 118 | Vaginal fistula (HP:0004320) | 2.30192183 |
| 119 | Increased IgE level (HP:0003212) | 2.29897159 |
| 120 | Increased IgM level (HP:0003496) | 2.29786438 |
| 121 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.28856019 |
| 122 | Keratoconjunctivitis (HP:0001096) | 2.27743331 |
| 123 | Myocardial infarction (HP:0001658) | 2.26338137 |
| 124 | Bone marrow hypocellularity (HP:0005528) | 2.26021295 |
| 125 | Diminished motivation (HP:0000745) | 2.25472941 |
| 126 | Progressive neurologic deterioration (HP:0002344) | 2.25033375 |
| 127 | Angiofibromas (HP:0010615) | 2.24043799 |
| 128 | Adenoma sebaceum (HP:0009720) | 2.24043799 |
| 129 | Basal cell carcinoma (HP:0002671) | 2.23261723 |
| 130 | Intestinal fistula (HP:0100819) | 2.21447972 |
| 131 | Recurrent fungal infections (HP:0002841) | 2.20944751 |
| 132 | Malnutrition (HP:0004395) | 2.17711725 |
| 133 | Prolonged neonatal jaundice (HP:0006579) | 2.17457529 |
| 134 | Hepatosplenomegaly (HP:0001433) | 2.17304889 |
| 135 | Cerebral hypomyelination (HP:0006808) | 2.17168610 |
| 136 | Breast aplasia (HP:0100783) | 2.17095380 |
| 137 | Pulmonary infiltrates (HP:0002113) | 2.16061445 |
| 138 | Nuclear cataract (HP:0100018) | 2.15500553 |
| 139 | Duplicated collecting system (HP:0000081) | 2.14079323 |
| 140 | Palmar hyperkeratosis (HP:0010765) | 2.13802659 |
| 141 | Vertebral clefting (HP:0008428) | 2.13052263 |
| 142 | Abnormal biliary tract morphology (HP:0012440) | 2.12712045 |
| 143 | Delayed puberty (HP:0000823) | 2.12423484 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11144995 |
| 145 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11144995 |
| 146 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11144995 |
| 147 | Myelodysplasia (HP:0002863) | 2.10771196 |
| 148 | Premature loss of primary teeth (HP:0006323) | 2.08406108 |
| 149 | Gingivitis (HP:0000230) | 2.08238686 |
| 150 | Purpura (HP:0000979) | 2.05222966 |
| 151 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.04886971 |
| 152 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.04578472 |
| 153 | Gastrointestinal carcinoma (HP:0002672) | 2.04578472 |
| 154 | Vasculitis (HP:0002633) | 2.02042514 |
| 155 | Abnormal number of incisors (HP:0011064) | 2.00839166 |
| 156 | Small intestinal stenosis (HP:0012848) | 2.00406276 |
| 157 | Duodenal stenosis (HP:0100867) | 2.00406276 |
| 158 | Gastrointestinal atresia (HP:0002589) | 2.00397137 |
| 159 | Vertebral fusion (HP:0002948) | 1.99113445 |
| 160 | Cellular immunodeficiency (HP:0005374) | 1.98815721 |
| 161 | Anorexia (HP:0002039) | 1.98307604 |
| 162 | Vertebral hypoplasia (HP:0008417) | 1.97223865 |
| 163 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.97223865 |
| 164 | Neoplasm of the colon (HP:0100273) | 1.95058856 |
| 165 | Horseshoe kidney (HP:0000085) | 1.94910289 |
| 166 | Asplenia (HP:0001746) | 1.94730007 |
| 167 | Squamous cell carcinoma (HP:0002860) | 1.93592425 |
| 168 | 11 pairs of ribs (HP:0000878) | 1.93470576 |
| 169 | Ovarian neoplasm (HP:0100615) | 1.93323925 |
| 170 | Microretrognathia (HP:0000308) | 1.91593902 |
| 171 | Upper motor neuron abnormality (HP:0002127) | 1.91416128 |
| 172 | Tongue fasciculations (HP:0001308) | 1.90546672 |
| 173 | T lymphocytopenia (HP:0005403) | 1.90535236 |
| 174 | Cleft eyelid (HP:0000625) | 1.90003443 |
| 175 | Sex reversal (HP:0012245) | 1.89299434 |
| 176 | Abnormal sex determination (HP:0012244) | 1.89299434 |
| 177 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.88875862 |
| 178 | Hemoptysis (HP:0002105) | 1.88578453 |
| 179 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.88199451 |
| 180 | Slow saccadic eye movements (HP:0000514) | 1.87481328 |
| 181 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.87114402 |
| 182 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.86776387 |
| 183 | Cheilitis (HP:0100825) | 1.84740073 |
| 184 | Mucopolysacchariduria (HP:0008155) | 1.82243412 |
| 185 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82243412 |
| 186 | Global brain atrophy (HP:0002283) | 1.81670197 |
| 187 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81545474 |
| 188 | Episodic fever (HP:0001954) | 1.81490075 |
| 189 | Polyneuropathy (HP:0001271) | 1.81413821 |
| 190 | Aplasia cutis congenita (HP:0001057) | 1.81223588 |
| 191 | Ectropion (HP:0000656) | 1.79302353 |
| 192 | Abnormality of iron homeostasis (HP:0011031) | 1.78994891 |
| 193 | Abnormality of T cell number (HP:0011839) | 1.78880102 |
| 194 | Recurrent viral infections (HP:0004429) | 1.78690124 |
| 195 | Skin ulcer (HP:0200042) | 1.78188956 |
| 196 | Hypergammaglobulinemia (HP:0010702) | 1.77905748 |
| 197 | Autoimmune hemolytic anemia (HP:0001890) | 1.76978350 |
| 198 | Ridged nail (HP:0001807) | 1.75936473 |
| 199 | Polygenic inheritance (HP:0010982) | 1.75909127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WEE1 | 4.22888083 |
| 2 | EPHA2 | 4.01334181 |
| 3 | NEK1 | 3.17121573 |
| 4 | BUB1 | 3.15304676 |
| 5 | CDK12 | 3.14450663 |
| 6 | TTK | 2.94415014 |
| 7 | MST1R | 2.74481900 |
| 8 | CDC7 | 2.60580311 |
| 9 | RPS6KB2 | 2.51731885 |
| 10 | EIF2AK1 | 2.41108929 |
| 11 | PASK | 2.25624861 |
| 12 | IRAK4 | 2.22951303 |
| 13 | PBK | 2.20778694 |
| 14 | MAP3K13 | 2.18679499 |
| 15 | AKT3 | 2.17948138 |
| 16 | MAP3K14 | 2.15012605 |
| 17 | TSSK6 | 2.06503474 |
| 18 | TBK1 | 1.99357016 |
| 19 | NEK2 | 1.96717015 |
| 20 | PLK1 | 1.93267815 |
| 21 | ZAP70 | 1.91136265 |
| 22 | PRPF4B | 1.88741649 |
| 23 | EPHB1 | 1.85294769 |
| 24 | MAP4K1 | 1.84990746 |
| 25 | RIPK4 | 1.81817499 |
| 26 | CDK7 | 1.80609063 |
| 27 | SRPK1 | 1.73291829 |
| 28 | TXK | 1.72107115 |
| 29 | ABL2 | 1.68860764 |
| 30 | ERN1 | 1.68760241 |
| 31 | GRK7 | 1.68400598 |
| 32 | TESK2 | 1.66337544 |
| 33 | FGR | 1.65659255 |
| 34 | SIK3 | 1.65265061 |
| 35 | MOS | 1.65206658 |
| 36 | EIF2AK3 | 1.58752522 |
| 37 | TAOK1 | 1.56093158 |
| 38 | MAPKAPK3 | 1.55564876 |
| 39 | NME2 | 1.55076123 |
| 40 | MAP3K8 | 1.52003290 |
| 41 | RIPK1 | 1.50536187 |
| 42 | TYK2 | 1.50336859 |
| 43 | JAK3 | 1.47930618 |
| 44 | PAK4 | 1.45734514 |
| 45 | ACVR1B | 1.45602552 |
| 46 | ATR | 1.42756435 |
| 47 | PLK3 | 1.42671511 |
| 48 | ALK | 1.39932437 |
| 49 | TLK1 | 1.37932154 |
| 50 | CHEK2 | 1.37208734 |
| 51 | VRK1 | 1.36773457 |
| 52 | AURKB | 1.36691958 |
| 53 | STK24 | 1.35136205 |
| 54 | IKBKE | 1.32685649 |
| 55 | TGFBR1 | 1.29584709 |
| 56 | BRD4 | 1.29544212 |
| 57 | MAP2K6 | 1.27146224 |
| 58 | STK10 | 1.25553528 |
| 59 | MST4 | 1.24903157 |
| 60 | AURKA | 1.24727721 |
| 61 | MET | 1.24451089 |
| 62 | PNCK | 1.21992366 |
| 63 | TGFBR2 | 1.21481293 |
| 64 | DYRK3 | 1.21364011 |
| 65 | MARK3 | 1.15582614 |
| 66 | ZAK | 1.13983924 |
| 67 | LMTK2 | 1.10985534 |
| 68 | CDK4 | 1.10674249 |
| 69 | PLK4 | 1.10174543 |
| 70 | CHEK1 | 1.09758879 |
| 71 | STK4 | 1.09695615 |
| 72 | CDC42BPA | 1.09498238 |
| 73 | MAP3K1 | 1.09239293 |
| 74 | PIM1 | 1.08762704 |
| 75 | BRSK2 | 1.07901713 |
| 76 | PDK2 | 1.07318964 |
| 77 | FLT3 | 1.06484547 |
| 78 | IRAK2 | 1.06314021 |
| 79 | BMPR2 | 0.96920782 |
| 80 | MAP3K5 | 0.96226349 |
| 81 | LATS2 | 0.95086360 |
| 82 | PRKCI | 0.93323113 |
| 83 | MAP3K12 | 0.91068177 |
| 84 | DDR2 | 0.88536193 |
| 85 | STK16 | 0.87062057 |
| 86 | PTK2 | 0.85668381 |
| 87 | STK38L | 0.85201249 |
| 88 | CDK2 | 0.84033696 |
| 89 | BRAF | 0.80617152 |
| 90 | RPS6KA4 | 0.80315392 |
| 91 | TESK1 | 0.80142555 |
| 92 | BCKDK | 0.79175820 |
| 93 | ATM | 0.77466310 |
| 94 | SCYL2 | 0.77181998 |
| 95 | ARAF | 0.76462377 |
| 96 | HCK | 0.75106011 |
| 97 | DYRK2 | 0.73412214 |
| 98 | MAP3K11 | 0.71407444 |
| 99 | MTOR | 0.71232798 |
| 100 | WNK3 | 0.69672343 |
| 101 | KDR | 0.69443737 |
| 102 | ERBB4 | 0.68958756 |
| 103 | CSNK2A2 | 0.68569910 |
| 104 | IRAK1 | 0.68462573 |
| 105 | LCK | 0.68085903 |
| 106 | EPHB2 | 0.66984706 |
| 107 | LIMK1 | 0.65778202 |
| 108 | MKNK1 | 0.64992061 |
| 109 | PAK1 | 0.64539257 |
| 110 | BMX | 0.64195729 |
| 111 | CSNK2A1 | 0.63589887 |
| 112 | MAP3K3 | 0.61865418 |
| 113 | SYK | 0.61496417 |
| 114 | LYN | 0.61416541 |
| 115 | MELK | 0.59879007 |
| 116 | TAOK2 | 0.59570793 |
| 117 | CDK6 | 0.59559283 |
| 118 | TTN | 0.58979927 |
| 119 | BTK | 0.58963370 |
| 120 | FES | 0.57982244 |
| 121 | TAOK3 | 0.57578599 |
| 122 | EIF2AK2 | 0.56067583 |
| 123 | EEF2K | 0.55070845 |
| 124 | MATK | 0.51487079 |
| 125 | MKNK2 | 0.50548074 |
| 126 | CDK1 | 0.50256209 |
| 127 | CSF1R | 0.50152114 |
| 128 | SIK1 | 0.48068363 |
| 129 | CHUK | 0.47584178 |
| 130 | MAP3K6 | 0.46299597 |
| 131 | PRKD2 | 0.44901555 |
| 132 | YES1 | 0.44275629 |
| 133 | KSR2 | 0.43933769 |
| 134 | IKBKB | 0.43900071 |
| 135 | SIK2 | 0.43053663 |
| 136 | PIM2 | 0.42662459 |
| 137 | LRRK2 | 0.42536697 |
| 138 | RPS6KA5 | 0.41978848 |
| 139 | CSNK1E | 0.41653042 |
| 140 | PRKG2 | 0.41121098 |
| 141 | JAK1 | 0.41006631 |
| 142 | MAP2K2 | 0.40681797 |
| 143 | ADRBK2 | 0.40413913 |
| 144 | MAP3K9 | 0.39037424 |
| 145 | PDK4 | 0.38855467 |
| 146 | PDK3 | 0.38855467 |
| 147 | PKN2 | 0.38778947 |
| 148 | CLK1 | 0.38676613 |
| 149 | CSNK1D | 0.38496326 |
| 150 | PDGFRB | 0.37815087 |
| 151 | PDPK1 | 0.37743450 |
| 152 | CSK | 0.36016347 |
| 153 | BLK | 0.35460552 |
| 154 | PTK6 | 0.35016632 |
| 155 | MAP2K3 | 0.34797336 |
| 156 | IRAK3 | 0.34379998 |
| 157 | ABL1 | 0.32368981 |
| 158 | JAK2 | 0.32296797 |
| 159 | PTK2B | 0.32056557 |
| 160 | AKT2 | 0.31085617 |
| 161 | NME1 | 0.31077432 |
| 162 | NTRK1 | 0.29223995 |
| 163 | MAPKAPK2 | 0.28502344 |
| 164 | GRK6 | 0.27408882 |
| 165 | ITK | 0.27308330 |
| 166 | CAMKK2 | 0.26269352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 4.47706487 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.18898745 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.74483487 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.43268467 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.26917740 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 3.13544360 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.11513509 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.97180430 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.92010795 |
| 10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.79055844 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.68071649 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.59815502 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.57384126 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.55914671 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.54629877 |
| 16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.53522664 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41240222 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 2.38392019 |
| 19 | Malaria_Homo sapiens_hsa05144 | 2.22011988 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 2.13490548 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.10953529 |
| 22 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.02410933 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.98018158 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.90893578 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74173096 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73399896 |
| 27 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.72393994 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70910263 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.69775256 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.69494678 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.66514919 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.64101009 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 1.63635783 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56223885 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55295817 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54799397 |
| 37 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.53951000 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51034868 |
| 39 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.50924475 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.47061642 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45531273 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43020131 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.41122004 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.37624735 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.37320332 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36931350 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35973640 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.33498986 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24447155 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22336252 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19973749 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18882527 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17080738 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15279685 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13174856 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11019771 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09758206 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08010385 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06356454 |
| 60 | Purine metabolism_Homo sapiens_hsa00230 | 1.05076258 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05052403 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 1.04242613 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02353915 |
| 64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.02090748 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.98439567 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97071141 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96776588 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96424758 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93472366 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91581934 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91479492 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.90879161 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89592762 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86350177 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85545724 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85368490 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84404638 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84335478 |
| 79 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.83522770 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.81944263 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81772881 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80944002 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79969672 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78271046 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78146077 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77620186 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.74127831 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73285619 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72825263 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72433983 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.70873845 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70153568 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67592914 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66144598 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65488683 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64748134 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60042414 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58226558 |
| 99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57975689 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55831023 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55064447 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52591460 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52435867 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51693413 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51345134 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50853200 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50426801 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48365279 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48292531 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47419048 |
| 111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45812125 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45661577 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45461892 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44907291 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44851930 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44334181 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43550923 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.42850431 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41951885 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41639895 |
| 121 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40582622 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40344595 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.39995649 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38738690 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38661728 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38100742 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.38060433 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37619052 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.37280409 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35450980 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35314341 |
| 132 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.35312714 |
| 133 | Leishmaniasis_Homo sapiens_hsa05140 | 0.35127852 |
| 134 | Adherens junction_Homo sapiens_hsa04520 | 0.34792409 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34328904 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34279379 |
| 137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34031600 |
| 138 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32573399 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31172324 |
| 140 | Asthma_Homo sapiens_hsa05310 | 0.30945084 |
| 141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29982055 |
| 142 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29810329 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29679658 |
| 144 | Shigellosis_Homo sapiens_hsa05131 | 0.27701125 |
| 145 | Bladder cancer_Homo sapiens_hsa05219 | 0.27373266 |
| 146 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27334032 |
| 147 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26100200 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.25602466 |
| 149 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.24774896 |
| 150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24362660 |
| 151 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.24111410 |
| 152 | Protein export_Homo sapiens_hsa03060 | 0.23491500 |
| 153 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20404996 |
| 154 | Salmonella infection_Homo sapiens_hsa05132 | 0.19683347 |
| 155 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19550242 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18771494 |
| 157 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.18443235 |
| 158 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17633642 |
| 159 | Mineral absorption_Homo sapiens_hsa04978 | 0.17377141 |
| 160 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.17006028 |
| 161 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.16163764 |
| 162 | Allograft rejection_Homo sapiens_hsa05330 | 0.16101871 |
| 163 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15268911 |

